Home   Contact Us   Sitemap
 



 Financial & IR Update  News Update  Annual Report 2013-14
 
Indoco Remedies Q3 Profit After Tax (PAT) grows by 53% - Q3 FY15
Unaudited Standalone Financial Results for the Quarter and Nine Months ended 31st December, 2014 - Q3 FY15
Management Discussion & Analysis - Q3 FY15
Conference Call Invitation - Q3 FY15
 
The Outperformers Indoco Remedies, Outlook Business - December 26, 2014
Indoco Remedies gets USFDA nod for Goa's sterile and solid dosage facilities - July 21, 2014
We will reach Rs 1,000-crore sales in a year-and-a-half - May 13, 2014
more »